Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile

Clinical trial NCT03321656 · RECRUITING

Trial details

NCT number: NCT03321656
Sponsor: Roberto Gedaly
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

End Stage Renal Disease

Start date: 2019-03-28
Primary completion: 2027-03-31
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.